Amgen kept by Bear Stearns at peer perform

Amgen Inc. was maintained by Bear Stearns analyst Mark Schoenebaum at a peer perform rating following a meeting with management. Bear Stearns came away with several incremental data points related to timing for data releases on Panitumumab and AMG-108, dialysis market dynamics and financial expectations for the second half of 2005. Amgen shares Wednesday were down $0.40, or 0.48%, at $82.37 on volume of 5,973,742 shares versus the three-month running average of 9,753,560 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.